Should I buy or sell Indivior stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Indivior in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" INDV shares. View INDV analyst ratings or view top-rated stocks .

What is Indivior's stock price target for 2024?

1 brokers have issued 1-year price objectives for Indivior's stock. Their INDV share price targets range from GBX 2,330 to GBX 2,700. On average, they predict the company's stock price to reach GBX 2,515 in the next twelve months. This suggests a possible upside of 60.1% from the stock's current price. View analysts price targets for INDV or view top-rated stocks among Wall Street analysts .

How have INDV shares performed in 2024?

Indivior's stock was trading at GBX 1,185 at the beginning of the year. Since then, INDV shares have increased by 32.6% and is now trading at GBX 1,571. View the best growth stocks for 2024 here .

Is Indivior a good dividend stock?

Indivior (LON:INDV) pays an annual dividend of GBX 15 per share and currently has a dividend yield of 4.48%. INDV has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 150,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

What other stocks do shareholders of Indivior own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Indivior investors own include Bigblu Broadband (BBB) , Futura Medical (FUM) , Directa Plus (DCTA) , Lakehouse (LAKE) , Aquila Services Group (AQSG) , Benchmark (BMK) , Bodycote (BOY) , CityFibre Infrastructure (CITY) , Deltex Medical Group (DEMG) and Kingfisher (KGF) .

How do I buy shares of Indivior?

Shares of INDV stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:INDV

Indivior (INDV) Share Price, News & Analysis

→ The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad)

Free INDV Stock Alerts

GBX 1,571

+6.00 (+0.38%)

(As of 04/15/2024 ET)

Compare

Today's Range: 1,522
▼
1,587
50-Day Range: 1,314
▼
1,764
52-Week Range: 1,125
▼
1,938

Volume: 434,856 shs
Average Volume: 380,093 shs
Market Capitalization: £2.14 billion

P/E Ratio: 157,100.00
Dividend Yield: 0.95%
Price Target: GBX 2,515

Stock Analysis Analyst Forecasts Chart Competitors Headlines Insider Trades

Get Indivior alerts:

Indivior MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 60.1% Upside
GBX 2,515 Price Target
Short Interest: N/A
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: -0.20
Based on 2 Articles This Week
Insider Trading: Selling Shares
£42.45 M Sold Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.77 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
Indivior has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Indivior has received no research coverage in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for INDV.

1.7

Dividend Strength

Dividend Leadership
Indivior is a leading dividend payer. It pays a dividend yield of 4.48%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Indivior does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Indivior is 150,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for INDV.

1.0

News and Social Media Coverage

News Sentiment
Indivior has a news sentiment score of -0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Indivior this week, compared to 0 articles on an average week.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Indivior insiders have sold more of their company's stock than they have bought. Specifically, they have bought GBX 0 in company stock and sold £424,476.69 in company stock.
Percentage Held by Insiders
Only 3.21% of the stock of Indivior is held by insiders.
Percentage Held by Institutions
92.94% of the stock of Indivior is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Indivior is 157,100.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 142.26.
Price to Earnings Ratio vs. Sector
The P/E ratio of Indivior is 157,100.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 245.50.
Price to Earnings Growth Ratio
Due to a projected decrease in earnings for Indivior, their PEG ratio cannot be calculated.

See Top Rated MarketRank™ Stocks Here

Ad Crypto Swap Profits

Did You Get Your Free Bitcoin Yet?

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

About Indivior Stock (LON:INDV)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder. The company also offers OPVEE nasal spray for opioid overdose reversal; and PERSERIS extended-release injectable suspension for the treatment of schizophrenia in adults. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that completed phase 1 clinical trial for the treatment of opioid use disorder (OUD); INDV-1000, a selective GABAb positive allosteric modulator, which is in pre-clinical development phase for the treatment of alcohol use disorder in collaboration with ADDEX therapeutics; INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc.; and CT-102, a digital therapeutic for the treatment of OUD in collaboration with Click Therapeutics. Further, the company is developing INDV-5004, a drinabant injection to treat acute cannabinoid overdose. It has a strategic partnership with Aelis Farma to develop AEF0117, a synthetic CB1 specific signaling inhibitor that is in phase 2B clinical trial for the treatment of cannabis use disorder. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

INDV Stock Price History

30 days | 90 days | 365 days | Advanced Chart

INDV Stock News Headlines

March 20, 2024 | insidertrades.com

Indivior PLC (LON:INDV) Insider Sells £170,577.33 in Stock

March 19, 2024 | insidertrades.com

Indivior PLC (LON:INDV) Insider Mark Crossley Sells 15,444 Shares

April 15, 2024 | Priority Gold (Ad)

Biden to Launch “FedNOW” [Move Your Money Now]

Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...

April 14, 2024 | nasdaq.com

Notable Two Hundred Day Moving Average Cross - INDV

April 12, 2024 | americanbankingnews.com

Indivior (LON:INDV) Stock Crosses Above 50-Day Moving Average of $1,593.76

March 12, 2024 | msn.com

This Nasal Spray Rapidly Reverses Effects Of Fentanyl Overdose And No, It's Not Naloxone

February 29, 2024 | markets.businessinsider.com

Indivior Says Final Court Approval Concludes Antitrust Multidistrict Litigation

February 24, 2024 | reuters.com

Europe's STOXX 600 at all-time high as Nvidia boosts global tech shares

April 15, 2024 | Priority Gold (Ad)

Biden to Launch “FedNOW” [Move Your Money Now]

February 22, 2024 | msn.com

Indivior weighs moving primary listing to U.S.

February 10, 2024 | finance.yahoo.com

Indivior PLC (LON:INDV) Shares Could Be 44% Below Their Intrinsic Value Estimate

January 18, 2024 | markets.businessinsider.com

Adial Announces Appointment of Tony Goodman as Chief Operating Officer

November 20, 2023 | finance.yahoo.com

Great week for Indivior PLC (LON:INDV) institutional investors after losing 22% over the previous year

November 9, 2023 | msn.com

Indivior PLC (INDV) Tops Q3 Earnings and Revenue Estimates

October 2, 2023 | finance.yahoo.com

Indivior PLC (INDV): Unveiling Its Market Value

September 26, 2023 | finance.yahoo.com

Indivior Publishes Real World Data Showing SUBLOCADE® May Reduce Non-Fatal Overdoses Among Individuals with Opioid Use Disorder in Canada

September 7, 2023 | finance.yahoo.com

Indivior PLC (INDV)'s True Worth: A Complete Analysis of Its Market Value

June 12, 2023 | finance.yahoo.com

The 7.5% return this week takes Indivior's (LON:INDV) shareholders three-year gains to 372%

June 12, 2023 | finance.yahoo.com

Indivior to Commence Trading on Nasdaq

June 7, 2023 | msn.com

Jefferies Reiterates Indivior (LSE:INDV) Buy Recommendation

June 5, 2023 | reuters.com

Indivior opioid settlement makes purer M&A case

June 3, 2023 | msn.com

US drugmaker Indivior to pay $102.5 million to settle Suboxone monopoly claims

June 2, 2023 | finanznachrichten.de

Indivior PLC: Indivior Reaches Agreement with States' Attorneys General and District of Columbia to Resolve Antitrust Multi-District Litigation Claims

May 25, 2023 | uk.finance.yahoo.com

INDV.L - Indivior PLC

May 25, 2023 | finance.yahoo.com

Indivior To Participate In Upcoming Investor Conferences

May 23, 2023 | finance.yahoo.com

Indivior PLC Form 20-F Registration Statement for Additional US Listing Now Available; Trading on NASDAQ Expected to Commence on June 12th

May 22, 2023 | markets.businessinsider.com

FDA Approves Opiant's Nasal Spray 'Opvee' To Reverse Opioid Overdose

See More Headlines

Receive INDV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Indivior and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: LON:INDV
CUSIP: N/A
CIK: N/A
Web: indivior.com
Phone: +44-1753-217800
Fax: N/A
Employees: 1,164
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: GBX 2,515
High Stock Price Target: GBX 2,700
Low Stock Price Target: GBX 2,330
Potential Upside/Downside: +60.1%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): GBX 0.01
Trailing P/E Ratio: 157,100.00
Forward P/E Ratio: 1,482.08
P/E Growth: -5.57
Net Income: £2 million
Net Margins: 0.18%
Pretax Margin: N/A
Return on Equity: 7.84%
Return on Assets: 8.73%

Debt

Debt-to-Equity Ratio: 240.17
Current Ratio: 0.97
Quick Ratio: 1.52

Sales & Book Value

Annual Sales: £1.09 billion
Price / Sales: 1.96
Cash Flow: GBX 586.17 per share
Price / Cash Flow: 2.68
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 135,940,000
Free Float: N/A
Market Cap: £2.14 billion
Optionable: Not Optionable
Beta: -0.05

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Mr. Mark Crossley
CEO & Executive Director
Mr. Ryan Preblick
CFO & Executive Director
Dr. Christian Heidbreder
Chief Scientific Officer
Mr. Jason Thompson
Vice President of Investor Relations
Ms. Cynthia Cetani
Chief Integrity & Compliance Officer
Mr. Jeffrey W. Burris (Age 52)
Chief Legal Officer
Mr. Jon Fogle
Chief Human Resources Officer
Mr. Richard Simkin
Chief Commercial Officer
Mr. Hillel West
Chief Manufacturing & Supply Officer
Mr. Vishal Kalia
SVP of US Treatment Access, Support Programs & Business Insights and Chief Impact & Strategy Officer

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

INDV Stock Analysis - Frequently Asked Questions

Should I buy or sell Indivior stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Indivior in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" INDV shares.
View INDV analyst ratings or view top-rated stocks.
What is Indivior's stock price target for 2024?: 1 brokers have issued 1-year price objectives for Indivior's stock. Their INDV share price targets range from GBX 2,330 to GBX 2,700. On average, they predict the company's stock price to reach GBX 2,515 in the next twelve months. This suggests a possible upside of 60.1% from the stock's current price.
View analysts price targets for INDV or view top-rated stocks among Wall Street analysts.
How have INDV shares performed in 2024?: Indivior's stock was trading at GBX 1,185 at the beginning of the year. Since then, INDV shares have increased by 32.6% and is now trading at GBX 1,571.
View the best growth stocks for 2024 here.
Is Indivior a good dividend stock?: Indivior (LON:INDV) pays an annual dividend of GBX 15 per share and currently has a dividend yield of 4.48%. INDV has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 150,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

What other stocks do shareholders of Indivior own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Indivior investors own include Bigblu Broadband (BBB), Futura Medical (FUM), Directa Plus (DCTA), Lakehouse (LAKE), Aquila Services Group (AQSG), Benchmark (BMK), Bodycote (BOY), CityFibre Infrastructure (CITY), Deltex Medical Group (DEMG) and Kingfisher (KGF).
How do I buy shares of Indivior?: Shares of INDV stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:INDV) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Indivior (INDV) Share Price, News & Analysis

Indivior MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Company Ownership

Earnings and Valuation

About Indivior Stock (LON:INDV)

INDV Stock Price History

INDV Stock News Headlines

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

INDV Stock Analysis - Frequently Asked Questions

Overall MarketRank^™